Search - tctmd.com

Displaying 561 - 580 of 630

Sort: Relevancy | Date

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

News Conference News AHA 2017

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Shelley Wood

November 14, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Conference News SCCT 2017

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Yael L. Maxwell

July 13, 2017

News Daily News

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Todd Neale

July 12, 2017

News Conference News EAS 2017

Perceived Financial Barriers to Healthcare Worsen Cardiovascular Outcomes Even in Countries With Universal Medical Coverage

Yael L. Maxwell

April 27, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

HEART Pathway as Safe as Usual Care for Chest Pain in the Emergency Department

Caitlin E. Cox

April 25, 2017

News Conference News ACC 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Yael L. Maxwell

March 23, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News AHA 2016

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Yael L. Maxwell

November 21, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

Advertisement

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Generic ARBs Linked to Increased Adverse Events

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Readmissions After Acute MI Not Only Confined to the Elderly

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Perceived Financial Barriers to Healthcare Worsen Cardiovascular Outcomes Even in Countries With Universal Medical Coverage

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

HEART Pathway as Safe as Usual Care for Chest Pain in the Emergency Department

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content